Nrf2 activator-encapsulating polymeric nanoparticles and LDL-like nanoparticles target atherosclerotic plaque
S. L. Maiocchi, S. Thai, A. Cartaya, A. Anwar, I. Corbin, E. M. Bahnson
This study develops and tests two types of nanoparticles that target atherosclerotic plaque to improve delivery of redox-based therapies.
bioRxiv · Jun 10, 2020 · PreprintBioengineering